Charm Therapeutics raised €69M in a Series B round in Sep 2025. The company is based in London, UK. Investors in the round: F-Prime Capital, Khosla Ventures, New Enterprise Associates (NEA) and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
